Dendreon Corp About
Dendreon Dendreon Corporation is a biotechnology company
focused on the discovery, development and commercialization of targeted therapies
for cancer. Their therapeutic vaccine, monoclonal antibody and small molecule
development capabilities provide them with a solid foundation on which to build
a variety of oncology treatments that meet these objectives. PRODUCT
CANDIDATES Their lead product candidate, Provenge®, an investigational
immunotherapy for the treatment of prostate
cancer. A second immunotherapy candidate, APC8024 (Neuvenge), is for
the treatment of HER-2/neu positive cancers, including breast, ovarian and colorectal
cancers. More
on Dendreon: Key
Statistics for Dendreon
Basic
Chart for Dendreon